GBp 956.2
(-0.15%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 506 Million | 750 Million | 699 Million | 591.4 Million | 455.8 Million | 411.4 Million |
Net Income | 270 Million | 490 Million | 396 Million | 375.7 Million | 121.7 Million | 339.3 Million |
Depreciation & Amortization | 379 Million | 341 Million | 313 Million | 276.7 Million | 330.8 Million | 88.1 Million |
Deferred income taxes | - | -777 Million | -588 Million | -590.7 Million | -730.8 Million | 98.2 Million |
Stock-based compensation | 16 Million | 19 Million | 16 Million | 12 Million | 2.8 Million | 15.7 Million |
Change in working capital | -166 Million | -76 Million | 54 Million | -25.3 Million | -66.4 Million | -113.9 Million |
Other non-cash items | 947 Million | 753 Million | 508 Million | 543 Million | 797.7 Million | -16 Million |
Investing Cash Flow | -231 Million | -153 Million | -167 Million | -93.1 Million | -154.1 Million | -124.5 Million |
Investments in PPE | -212 Million | -179 Million | -165 Million | -117.7 Million | -154.4 Million | -62.6 Million |
Acquisitions | -19 Million | 26 Million | 5 Million | 24.59 Million | 299.99 Thousand | -25 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -19 Million | -11 Million | -7 Million | 1.00 | 1.00 | -36.9 Million |
Financing Cash Flow | -865 Million | -815 Million | -578 Million | -156.5 Million | -260.2 Million | -343.4 Million |
Debt repayment | -231 Million | -210 Million | -202 Million | -4.7 Million | -300 Million | -161.2 Million |
Dividends payments | -233 Million | -203 Million | -219 Million | - | -175.2 Million | -171.1 Million |
Common Stock Repurchased | -402 Million | -405 Million | -161 Million | -100 Thousand | -150.7 Million | -163.5 Million |
Common Stock Issuance | 1 Million | 3 Million | 4 Million | 2.2 Million | 3.8 Million | 2.3 Million |
Other Financing Activities | 1 Million | -6 Million | -3 Million | -1.7 Million | 361.9 Million | 150.1 Million |
Accounts receivables | -32 Million | -17 Million | -5 Million | -39 Million | -9.8 Million | -54.6 Million |
Accounts payables | -77 Million | -49 Million | 81 Million | -7.2 Million | -84 Million | 54.9 Million |
Inventory | -57 Million | -10 Million | -22 Million | 20.9 Million | 27.4 Million | -59.3 Million |
Other working capital | -77 Million | - | - | - | - | -54.9 Million |
Cash at beginning of period | 1.02 Billion | 1.22 Billion | 1.26 Billion | 928.9 Million | 874.5 Million | 892.1 Million |
Cash at end of period | 180 Million | 1.02 Billion | 1.22 Billion | 1.26 Billion | 928.9 Million | 837.3 Million |
Capital Expenditure | -212 Million | -179 Million | -165 Million | -117.7 Million | -154.4 Million | -62.6 Million |
Effect of forex changes on cash | -9 Million | 2 Million | 7 Million | -13 Million | 8.5 Million | 1.7 Million |
Net cash flow / Change in cash | -846 Million | -196 Million | -39.3 Million | 332.4 Million | 54.4 Million | -54.8 Million |
Free Cash Flow | 294 Million | 571 Million | 534 Million | 473.7 Million | 301.4 Million | 348.8 Million |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 270 Million | 112 Million | 158 Million | 297 Million | 490 Million | 193 Million |
Depreciation & Amortization | 379 Million | 200 Million | 179 Million | 178 Million | 341 Million | 163 Million |
Deferred income taxes | - | - | -519 Million | -316 Million | -777 Million | -461 Million |
Stock-based compensation | 16 Million | 9 Million | 7 Million | 9 Million | 19 Million | 10 Million |
Change in working capital | -166 Million | 45 Million | -154 Million | 49 Million | -76 Million | -125 Million |
Other non-cash items | 947 Million | -31 Million | 500 Million | 321 Million | 753 Million | 432 Million |
Investing Cash Flow | -231 Million | -141 Million | -90 Million | -116 Million | -153 Million | -37 Million |
Investments in PPE | -212 Million | -94 Million | -90 Million | -126 Million | -179 Million | -53 Million |
Acquisitions | -19 Million | -19 Million | - | 10 Million | 26 Million | 16 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -19 Million | -28 Million | -26 Million | -15 Million | -11 Million | 4 Million |
Financing Cash Flow | -865 Million | -401 Million | -464 Million | -401 Million | -815 Million | -414 Million |
Debt repayment | -231 Million | - | -96 Million | -221 Million | -210 Million | -93 Million |
Dividends payments | -233 Million | -66 Million | -167 Million | -63 Million | -203 Million | -140 Million |
Common Stock Repurchased | -402 Million | -201 Million | -201 Million | -223 Million | -405 Million | -182 Million |
Common Stock Issuance | 1 Million | 1 Million | 297 Million | 2 Million | 3 Million | 1 Million |
Other Financing Activities | 1 Million | -134 Million | -297 Million | -115 Million | -6 Million | -5 Million |
Accounts receivables | -32 Million | 26 Million | -58 Million | 36 Million | -17 Million | -53 Million |
Accounts payables | -77 Million | -57 Million | -20 Million | -23 Million | -49 Million | -26 Million |
Inventory | -57 Million | 19 Million | -76 Million | 36 Million | -10 Million | -46 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 1.02 Billion | 570 Million | 1.02 Billion | 1.01 Billion | 1.22 Billion | 1.22 Billion |
Cash at end of period | 180 Million | 441 Million | 663 Million | 1.02 Billion | 1.02 Billion | 1.01 Billion |
Capital Expenditure | -212 Million | -94 Million | -90 Million | -126 Million | -179 Million | -53 Million |
Effect of forex changes on cash | -9 Million | -1 Million | -8 Million | -1 Million | 2 Million | 3 Million |
Net cash flow / Change in cash | -846 Million | -129 Million | -363 Million | 9 Million | -196 Million | -205 Million |
Free Cash Flow | 294 Million | 241 Million | 81 Million | 412 Million | 571 Million | 159 Million |
600761
INGA
EVER
600714
600603
KBCA